577 news items
Page 20 of 29
fm1w9d857f95pgrwn456lqr4
BMY
29 Apr 24
(NYSE:BMY) to develop tolerizing vaccines for up to three autoimmune diseases. The collaboration aims to develop efficacious
5w86gc2ho0sgqqqe7zob1ozoeo36m5e19dmy
26 Apr 24
reference biologics, and treat illnesses like rheumatoid arthritis, inflammatory bowel disease, some cancers, psoriasis, diabetes, macular degeneration
9sh8j
TAK
26 Apr 24
in the European Union, Fruquintinib Will Be the First Novel Targeted Therapy for Metastatic Colorectal Cancer Regardless of Biomarker Status in Over
endcyxy5kyxq2w ut
AMST
HCA
HOOK
26 Apr 24
) application by the United States Food and Drug Administration (FDA) for HB 700. This product is a distinctive arenaviral therapeutic vaccine
1lol3d2n5fs49olqmbtnduevqpkfxm59boy9
MRK
25 Apr 24
cancer immunotherapy Keytruda largely drove the growth. Keytruda generated $6.95 billion in revenue during the quarter, up 20% from the year
6phixxpgdzhlexib91iigz4wb490u08lpjdxvnebaciqsyt3wwjwx7d
ELTX
25 Apr 24
-peptide formulation of Elicio's off-the-shelf investigational therapeutic cancer vaccine candidate, ELI-002 7P, in patients with mKRAS-driven solid tumors
uvmi8xa95ca4z4m0hgsqknxz4088x3y
SNGX
25 Apr 24
thermostabilized Ebola vaccines MarVax™ and SuVax™
ae4644beifi6lqqakhcp9pftbx3k20j892yiz3abjvo5aopzq4j8655y
MRK
25 Apr 24
development of a new investigational, multi-valent HPV vaccine designed to provide broader protection against certain cancers and diseases caused
oa9rkw7yve4alj7ch2ixe0 jar3zuisxjv6dtrepuvy
25 Apr 24
the necessary pieces in place for some time, including discussions with the Hospital of the University of Pennsylvania, one of the leading cancer
y9a5gvat8qihf9r21aec y0uur01d073
AZN
25 Apr 24
and Tagrisso that were unprecedented in lung cancer, the data from both of these studies will be presented during the ASCO plenary in June. We are also
sun99skppumoizwxllo1djf4sk7yzkya
25 Apr 24
Vaccines sales up 5.6%, boosted by BeyfortusConsumer Healthcare (CHC) up 9.0%, benefiting from
f30 mg8kvcn0wnjnhdsij5p3
IBRX
25 Apr 24
the development of potential cancer vaccines, as well as developing immunotherapies and cell therapies that we believe sharply reduce or eliminate
5vw9qs56nc0p79d2rdhz2icrbjyz7i26m 32knxx1h7myyjwibrw2vbfvh7e
IOBT
24 Apr 24
biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, today announced
4uknyd0rovbal1hxk3gd 51wy2011c4dm
24 Apr 24
cancer cells. The Company's clinical-stage programs consist of a portfolio of therapeutic vaccines and oncolytic viruses: TG4050